Ambey Laboratories Limited — Important, 14-11-2024: Updates

Ambey Laboratories Limited has submitted revised financial results due to a typographical error in its previously reported Earnings Per Share (EPS), correcting it from 0.16 to 1.38 for the half-year ended September 30, 2024. This adjustment emphasizes the company's commitment to transparent financial reporting. For this period, total revenue from operations stood at ₹67.65 crore, reflecting a solid performance compared to the previous half-year. Profit before tax was ₹36.12 crore, leading to a net profit of ₹29.66 crore after accounting for tax expenses. The company reported a significant increase in paid-up equity share capital to ₹24.95 crore, following an initial public offering (IPO) that raised funds primarily for working capital needs. Overall, the revised results reinforce Ambey Laboratories' operational strength and a positive outlook moving forward. Investors should monitor future developments closely, particularly regarding capital utilization and market expansion.